A Study of HQP1351 in Patients With GIST or Other Solid Tumors

Clinical trial NCT03594422 · RECRUITING

Trial details

NCT number: NCT03594422
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor (GIST)Solid Tumor, Adult

Start date: 2018-07-11
Primary completion: 2027-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.